Peimin Yu

No.12, Middle Wulumuqi Road
Jing'an, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Long-term efficacy of adjunctive cenobamate: Open-label extension of a randomized, placebo-controlled study in a multinational Asian population.

Long-term efficacy of adjunctive cenobamate: Open-label extension of a randomized, placebo-controlled study in a multinational Asian population.

Journal: Epilepsia

Published: May 07, 2026

Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure.

Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure.

Journal: Advances in therapy

Published: September 12, 2025

Clinical practice guidelines for the administration of third-generation anti-seizure medications.

Clinical practice guidelines for the administration of third-generation anti-seizure medications.

Journal: Seizure

Published: September 04, 2025

Efficacy and safety of Brivaracetam as an adjunctive therapy in patients with focal-onset seizures: a phase III, multi-center, randomized, double-blind, placebo-controlled trial.

Efficacy and safety of Brivaracetam as an adjunctive therapy in patients with focal-onset seizures: a phase III, multi-center, randomized, double-blind, placebo-controlled trial.

Journal: Acta epileptologica

Published: August 21, 2025

Efficacy of adjunctive cenobamate by focal seizure subtypes: a randomized, double-blind, placebo-controlled, multicenter study in a multinational Asian population.

Efficacy of adjunctive cenobamate by focal seizure subtypes: a randomized, double-blind, placebo-controlled, multicenter study in a multinational Asian population.

Journal: Seizure

Published: July 10, 2025

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures.

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures.

Journal: Epilepsia

Published: July 02, 2025

Sodium channel blockers for the treatment of focal epilepsy: A Chinese expert consensus.

Sodium channel blockers for the treatment of focal epilepsy: A Chinese expert consensus.

Journal: Seizure

Published: January 03, 2025

Temporal trends, in-hospital outcomes, and risk factors of acute myocardial infarction among patients with epilepsy in the United States: a retrospective national database analysis from 2008 to 2017.

Temporal trends, in-hospital outcomes, and risk factors of acute myocardial infarction among patients with epilepsy in the United States: a retrospective national database analysis from 2008 to 2017.

Journal: Frontiers in neurology

Published: February 19, 2024

Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring.

Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: February 01, 2023

The clinical features of familial focal epilepsy with variable foci and NPRL3 gene variant.

The clinical features of familial focal epilepsy with variable foci and NPRL3 gene variant.

Journal: PloS one

Published: October 08, 2022

Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study.

Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study.

Journal: Advances in therapy

Published: September 30, 2022

Crosstalk between Hh and Wnt signaling promotes osteosarcoma progression.

Crosstalk between Hh and Wnt signaling promotes osteosarcoma progression.

Journal: International journal of clinical and experimental pathology

Published: November 26, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026